{"id":487449,"date":"2021-05-05T06:33:36","date_gmt":"2021-05-05T10:33:36","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/amerisourcebergen-reports-fiscal-2021-second-quarter-results\/"},"modified":"2021-05-05T06:33:36","modified_gmt":"2021-05-05T10:33:36","slug":"amerisourcebergen-reports-fiscal-2021-second-quarter-results","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/amerisourcebergen-reports-fiscal-2021-second-quarter-results\/","title":{"rendered":"AmerisourceBergen Reports Fiscal 2021 Second Quarter Results"},"content":{"rendered":"

<\/p>\n

AmerisourceBergen Reports Fiscal 2021 Second Quarter Results<\/b><\/p>\n

Revenues of $49.2 billion for the Second Quarter, a 3.7 Percent Increase Year-Over-Year<\/i><\/p>\n

Second Quarter GAAP Diluted EPS of $2.10 and Adjusted Diluted EPS of $2.53<\/i><\/p>\n

Adjusted Diluted EPS Guidance Range Raised to $8.45 to $8.60 for Fiscal 2021<\/i><\/p>\n

CONSHOHOCKEN, Pa.–(BUSINESS WIRE<\/a>)–
\nAmerisourceBergen Corporation (NYSE: ABC) today reported that in its fiscal year 2021 second quarter ended March 31, 2021, revenue increased 3.7 percent year-over-year to $49.2 billion. On the basis of U.S. generally accepted accounting principles (GAAP), diluted earnings per share (EPS) was $2.10 for the March quarter of fiscal 2021, compared to $4.64 in the prior year quarter. Adjusted diluted EPS, which is a non-GAAP measure that excludes items described below, increased 5.4 percent to $2.53 in the fiscal second quarter.\n<\/p>\n

\nAmerisourceBergen is updating its outlook for fiscal year 2021. The Company does not provide forward-looking guidance on a GAAP basis, as discussed below in Fiscal Year 2021 Expectations. Adjusted diluted EPS guidance has been raised from the previous expectation of $8.40 to $8.60 to a range of $8.45 to $8.60, reflecting growth of 7 percent to 9 percent versus the previous fiscal year.\n<\/p>\n

\n“AmerisourceBergen continues to prove our vital role as a key pillar in the healthcare system. Our solid performance in the March quarter was fueled by our associates who continue to work diligently to provide innovative solutions for our partners to ultimately serve their patients,” said Steven H. Collis, Chairman, President and Chief Executive Officer of AmerisourceBergen.\n<\/p>\n

\n“Driven by our purpose of being united in our responsibility to create healthier futures, we are strengthening our portfolio of solutions for customers, expanding on our leadership in specialty, focusing on execution and leveraging our capabilities and expertise to support pharmaceutical innovation,” Mr. Collis continued. “AmerisourceBergen is well-positioned to deliver long-term, sustainable growth, supported by our diverse and inclusive teams and our investments in our people and culture.”\n<\/p>\n

Second Quarter Fiscal Year 2021 Summary Results <\/span><\/b><\/p>\n\n\n\n\n\n\n\n\n\n\n\n
\n

\n\u00a0\n<\/p>\n<\/td>\n

\n\n

GAAP<\/b><\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

\n

Adjusted (Non-GAAP)<\/b><\/p>\n<\/td>\n<\/tr>\n

\n

Revenue<\/b><\/p>\n<\/td>\n

\n\n

$49.2B<\/i><\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

\n

$49.2B<\/i><\/p>\n<\/td>\n<\/tr>\n

\n

Gross Profit<\/b><\/p>\n<\/td>\n

\n\n

$1.5B<\/i><\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

\n

$1.5B<\/i><\/p>\n<\/td>\n<\/tr>\n

\n

Operating Expenses<\/b><\/p>\n<\/td>\n

\n\n

$909M<\/i><\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

\n

$806M<\/i><\/p>\n<\/td>\n<\/tr>\n

\n

Operating Income<\/b><\/p>\n<\/td>\n

\n\n

$624M<\/i><\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

\n

$707M<\/i><\/p>\n<\/td>\n<\/tr>\n

\n

Interest Expense, Net<\/b><\/p>\n<\/td>\n

\n\n

$35M<\/i><\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

\n

$35M<\/i><\/p>\n<\/td>\n<\/tr>\n

\n

Effective Tax Rate<\/b><\/p>\n<\/td>\n

\n\n

23.4%<\/i><\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

\n

21.9%<\/i><\/p>\n<\/td>\n<\/tr>\n

\n

Net Income Attributable to ABC<\/b><\/p>\n<\/td>\n

\n\n

$435M<\/i><\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

\n

$524M<\/i><\/p>\n<\/td>\n<\/tr>\n

\n

Diluted Earnings Per Share<\/b><\/p>\n<\/td>\n

\n\n

$2.10<\/i><\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

\n

$2.53<\/i><\/p>\n<\/td>\n<\/tr>\n

\n

Diluted Shares Outstanding<\/b><\/p>\n<\/td>\n

\n\n

207M<\/i><\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

\n

207M<\/i><\/p>\n<\/td>\n<\/tr>\n<\/table>\n

\nBelow, AmerisourceBergen presents descriptive summaries of the Company\u2019s GAAP and adjusted (non-GAAP) quarterly results. In the tables that follow, GAAP results and GAAP to non-GAAP reconciliations are presented. For more information related to non-GAAP financial measures, including adjustments made in the periods presented, please refer to the “Supplemental Information Regarding non-GAAP Financial Measures” following the tables.\n<\/p>\n

Second Quarter GAAP Results<\/span><\/b><\/p>\n